These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16356602)

  • 21. Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen.
    Saini V; Jain V; Sudheesh MS; Jaganathan KS; Murthy PK; Kohli DV
    Int J Pharm; 2011 Apr; 408(1-2):50-7. PubMed ID: 21291968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles.
    Carcaboso AM; Hernández RM; Igartua M; Rosas JE; Patarroyo ME; Pedraz JL
    Vaccine; 2004 Mar; 22(11-12):1423-32. PubMed ID: 15063565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodegradable microparticles as controlled release antigen delivery systems.
    O'Hagan DT; Rahman D; McGee JP; Jeffery H; Davies MC; Williams P; Davis SS; Challacombe SJ
    Immunology; 1991 Jun; 73(2):239-42. PubMed ID: 2071168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
    Chong CS; Cao M; Wong WW; Fischer KP; Addison WR; Kwon GS; Tyrrell DL; Samuel J
    J Control Release; 2005 Jan; 102(1):85-99. PubMed ID: 15653136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasal vaccination with poly(lactide-co-glycolide) microparticles containing a peptide T of Ole e 1 prevents mice against sensitization.
    Marazuela EG; Prado N; Moro E; Fernández-García H; Villalba M; Rodríguez R; Batanero E
    Clin Exp Allergy; 2008 Mar; 38(3):520-8. PubMed ID: 18205856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study.
    Uchida T; Goto S
    Biol Pharm Bull; 1994 Sep; 17(9):1272-6. PubMed ID: 7841952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG; Mitra AK
    Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PLGA-dendron nanoparticles enhance immunogenicity but not lethal antibody production of a DNA vaccine against anthrax in mice.
    Ribeiro S; Rijpkema SG; Durrani Z; Florence AT
    Int J Pharm; 2007 Mar; 331(2):228-32. PubMed ID: 17258876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant.
    Guo L; Chen J; Qiu Y; Zhang S; Xu B; Gao Y
    Int J Pharm; 2013 Apr; 447(1-2):22-30. PubMed ID: 23410987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles.
    Pai Kasturi S; Qin H; Thomson KS; El-Bereir S; Cha SC; Neelapu S; Kwak LW; Roy K
    J Control Release; 2006 Jul; 113(3):261-70. PubMed ID: 16793161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines.
    Waeckerle-Men Y; Groettrup M
    Adv Drug Deliv Rev; 2005 Jan; 57(3):475-82. PubMed ID: 15560953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.
    Jiang W; Gupta RK; Deshpande MC; Schwendeman SP
    Adv Drug Deliv Rev; 2005 Jan; 57(3):391-410. PubMed ID: 15560948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency.
    Kazzaz J; Singh M; Ugozzoli M; Chesko J; Soenawan E; O'Hagan DT
    J Control Release; 2006 Feb; 110(3):566-73. PubMed ID: 16360956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly (D, L-lactide-co-glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo.
    Stern M; Ulrich K; Geddes DM; Alton EW
    Gene Ther; 2003 Aug; 10(16):1282-8. PubMed ID: 12883524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice.
    Prior S; Gander B; Irache JM; Gamazo C
    J Antimicrob Chemother; 2005 Jun; 55(6):1032-6. PubMed ID: 15883176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response to ovalbumin following bisphenol A administration in mice fed with a low level of dietary protein.
    Alizadeh M; Ota F; Kassu A
    J Microbiol Immunol Infect; 2007 Aug; 40(4):364-70. PubMed ID: 17712472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immune response to a model antigen associated with PLG microparticles prepared using different surfactants.
    Rafati H; Lavelle EC; Coombes AG; Stolnik S; Holland J; Davis SS
    Vaccine; 1997 Dec; 15(17-18):1888-97. PubMed ID: 9413098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.
    Delgado A; Lavelle EC; Hartshorne M; Davis SS
    Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
    Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
    J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly (DL-lactide-co-glycolide) microparticles as carriers for antimycobacterial drug rifampicin.
    Dutt M; Khuller GK
    Indian J Exp Biol; 2000 Sep; 38(9):887-94. PubMed ID: 12561946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.